RSS

RIGH Rightsmile Inc.

Mod: john1234 Asst: BURN.NOTICE88
Last Post: 04/15/19
Followers: 34
Posts Today: 0
Views Today: 2699

RIGH Stock Quote & Tools

$0.0000 ▲ +0.0000 (+0.00%) As of Oct 8, 3:09 PM EDT
Last0.0000
$ Chg0.0000
Open—
High—
Beta-56.1769
Year High0.000
Market Cap—
P/B Ratio—
EPS—
Avg Vol (30d)13.9K
Volume0
% Chg+0.00%
Prev Close0.0000
Low—
VWAP0.00000
Year Low0.000
Total Shares—
Shares Out—
Float—
ExchangeOTCID
Utilities Regulated Utilities

RIGH Stock Message Board Discussion

  1. john1234
  2. john1234
  3. Hopeful
  4. Godspeed
  5. john1234
  6. john1234
  7. ebiljoe
  8. john1234
  9. john1234
  10. Hopeful
  11. john1234

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 359

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Chipotle's BOGO Promo Returns: Tattoos Boost Sales

Updated Category News Views 26

Chipotle's BOGO Charade: A Tattooed Affair You've got to hand it to Chipotle—they know how to turn heads and wallets with their quirky promotions. The upcoming 'Tatted Like a Chipotle Bag' offer is a prime example of how they ride the cultural zeitgeist as they gear up for another record-breaking day on Friday, November 13. And seriously, with tattoos in play, they're...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 157

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 525

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
CHARMANT Eyewear Fuses Fashion and Functionality

Updated Category News Views 38

Eyewear ain’t just about seeing clearly anymore—it’s fashion with a capital ‘F’. The CHARMANT Japanese Made brand decided to foist this idea upon the world, putting their money where your eyeballs are, by injecting a dose of trendy glam into what they already do so well: comfort. Fusion of Style and Comfort Catch this: CHARMANT hit the global stage back in June...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 240

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Onodrim Raises $300M to Propel EU Defence Future

Updated Category News Views 119

Onodrim Industries' Bold Bid to Reshape European Security Right out of the gate, Onodrim Industries is thundering onto the scene with a hefty $300 million Series A round to flex its muscles across Europe's defence and industrial sectors. This ain't your run-of-the-mill startup story. This is about flexing hard-earned capital to snap up established players and inject a...

Continue Reading
Photocure Navigates AssureMDx's Medicare Journey

Updated Category News Views 99

Aiming High with AssureMDx Photocure's got this bladder cancer test called AssureMDx that's at the center of its recent moves after acquiring Vesica Health a few months back. This isn't just any test; it's a urine-based, non-invasive way to snag an early look at bladder cancer. With the FDA's Breakthrough Device tag pinned on, they're not just dipping their toes in—this...

Continue Reading
Children's Institute Gala Raises $4M: A Night to Remember

Updated Category News Views 42

Breaking Records and Honoring Legends You know, sometimes there's more to the world than stocks and ticker tapes. Over in Los Angeles, the Children's Institute pulled off a real spectacle with their Annual Cape & Gown Gala, drawing in more than 600 folks and raking in a whopping $4 million. That's right, four million clams in one evening—a record-breaker for them. When...

Continue Reading
Expedera Teams Up with Cadence for Edge AI Supercharge

Updated Category News Views 16

A New Power Couple in AI Expedera and Cadence have decided to stir up the edge AI waters with their latest collaboration. By linking Expedera's Origin™ Evolution NPU with Cadence's Tensilica NeuroEdge 130 AI Co-Processor, we're looking at a partnership that's hell-bent on redefining efficiency and performance in edge AI systems. Breaking Down the Collaboration This...

Continue Reading

Top 5 Most Recently Viewed Articles

USA Rare Earth Prepares for Q1 2025 Results and Call

Updated Category News Views 364

Upcoming Financial Results Announcement USA Rare Earth, Inc. (Nasdaq: USAR) is gearing up to unveil its financial performance for the first quarter of 2025. Investors and stakeholders can look forward to the results being released after U.S. markets close on May 14, 2025. This marks an important date for the company as they reflect on their financial journey during the...

Continue Reading
Innovative Prostate Cancer Trial Launches with TLX591 in Miami

Updated Category News Views 111

Telix Pharmaceuticals Initiates Groundbreaking Trial Telix Pharmaceuticals Limited (NASDAQ: TLX) has taken exciting steps in prostate cancer treatment with the commencement of the ProstACT Global Phase 3 clinical trial. This innovative trial is taking place at the Biogenix Molecular Research Center, focusing on TLX591, a novel radiopharmaceutical designed for patients...

Continue Reading
Alstom S.A. Reports on Half-Year Liquidity for 2024

Updated Category News Views 266

Overview of Alstom's Liquidity Statement As part of its ongoing commitment to transparency and reporting, Alstom S.A. recently published its half-year liquidity contact statement. This statement reflects the company's financial health and activities surrounding its liquidity contract with Rothschild Martin Maurel. As of the end of the previous fiscal period, Alstom...

Continue Reading
Vulcan Materials Company: Strong 2024 Financial Performance

Updated Category News Views 538

Vulcan Materials Company Reports Exceptional Financial Results Vulcan Materials Company (NYSE: VMC), recognized as the largest producer of construction aggregates in the United States, has published its outstanding financial results for the 2024 fiscal year. The company has demonstrated remarkable execution, resulting in significant margin expansion and growth in...

Continue Reading
Local Logic and BHS Join Forces to Transform Real Estate

Updated Category News Views 254

Local Logic and Brown Harris Stevens Form Strategic Alliance In an exciting development within the real estate sector, Local Logic, a top-tier location intelligence company, has announced a strategic partnership with Brown Harris Stevens (BHS), a leader in the luxury real estate market. This collaboration signifies a shared commitment to leveraging groundbreaking...

Continue Reading